Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...

Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...

Q4 2025 Earnings Call February 12, 2026 4:30 AM ESTCompany ParticipantsTadeu Marroco - CEO, Member of Management ...

A 'special meeting' has been set up for March 20th to approve the Warner Bros. Discovery-Netflix sale—details in the article.

None ...

The WBD-Netflix Transaction Delivers Incredible Value and Certainty to WBD Stockholders with Clear Path to Timely Regulatory ApprovalNetflix is the ...

The WBD-Netflix Transaction Delivers Incredible Value and Certainty to WBD Stockholders with Clear Path to Timely Regulatory ApprovalNetflix is the Superior Deal and the Only Deal Before WBD ...

CEO Kishore Seendripu opened by describing 2025 as a “clear inflection year with resurgent growth,” highlighting 30% year-over-year revenue growth, profitability, and positive cash flow ahead of plan.

A month has gone by since the last earnings report for Netflix (NFLX). Shares have lost about 8.6% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent ...

Umbrella or sun cap? Buy or sell stocks? When it comes to questions like these, many people today rely on AI-supported recommendations. Chatbots such as ChatGPT, AI-driven weather forecasts, and ...